What will it take to make neurotechnology part of everyday life? In this episode, Adam Fraser is joined by Dorian Haci, co-founder and CEO of MintNeuro, to explore the business behind the chips that power neural devices and BCIs. In their conversation, Dorian shares his perspective on building a company that helps other innovators move forward and turns scientific ambition into something people can use. They explore his ambition to make neurotech more accessible, the importance of creating real-world value and the possibilities of a closer relationship with technology. They also delve into the drive to solve meaningful problems, the value of learning from others and the long-term view behind lasting innovation. Tune in to learn about the decisions and relationships shaping neurotech’s next chapter.
Key Points From This Episode:
- [01:33] Meet Dorian and hear how his electronics background led him to MintNeuro.
- [02:56] Discover why Dorian chose to use electronics to address neurological conditions.
- [03:58] Learn why hardware bottlenecks caused MintNeuro’s move out of academia.
- [06:17] Understand how neurotech chips differ from processors used for computing.
- [09:22] Explore why MintNeuro builds modular, function-specific chips for neural devices.
- [12:25] Hear why Dorian favours close customer partnerships over selling off-the-shelf chips.
- [16:16] Unpack how he defines the BCI landscape and its place within wider neurotech.
- [22:05] Where companies could compete as the BCI supply chain becomes specialised.
- [27:31] Uncover why investors are backing BCI despite its long path to commercial scale.
- [31:13] Assess how grants and investors have supported MintNeuro’s progress to market.
- [33:41] MintNeuro's funding requirements and their strategy for scaling globally.
- [36:33] Find out how Dorian adapted from designing chips to leading a business.
- [39:33] Final takeaways and how to connect with Dorian and follow MintNeuro’s progress.
Links Mentioned in Today’s Episode:
Dorian Haci on LinkedIn
MintNeuro
MintNeuro on LinkedIn
Motif
Amber Therapeutics
Episode 5: Naveen Rao Talks Neurotech Market Dynamics
Phase Lock
Adam Fraser on LinkedIn
Omniscient Neurotechnology
The Business of Neurotech Podcast